This project will optimize an existing innovative method for performing high-throughput screening assays using engineered tissues that mimic the myocardium and a novel, screening instrument that can rapidly measure the mechanical properties of those tissues. Our engineered tissues significantly reduce the need for whole animal testing. In the proposed research, we will focus on refining our heart tissue model growing in a 96-well format. We will produce samples with identical physiological properties that have Z-factors >0.5 in high-throughput screening assays using our screening instrument. We will perform a blind screen using known compounds with known effects on myocardium to evaluate our measure of success. Further, we will test 3 drugs, known to affect cardiovascular functions, using an established toxicity assay and our engineered tissue assay system and correlate the results. Our strategic business partner, Gilson, Inc. (Middleton, WI), which has more than 50 years of business development experience in the life science industry, will collaborate with us on the engineering efforts to improve our screening instrument and develop consumable products with our engineered tissues. After confirming the usefulness and reproducibility of the assay, we will profile a small library of plant extracts from the Philippines. The full library of extracts (16,000 samples) is available only to scientists at the Medical College of Wisconsin who collaborate on this project. NCI has previously screened and ranked the extracts in this library for cytotoxicity on HL60 cells. The sub-library consists of 1,045 extracts that showed the lowest toxicity in the NCI study. We will identify """"""""hit"""""""" extracts by their ability to alter 2 important parameters of myocardial contraction measured by our tissue assay system. In Phase II studies, we will focus on characterizing the active components in any extracts that changed myocardial contraction in our assay and screening and profiling the entire library. The ultimate goal of this project is to rapidly and cost-effectively identify an herbal remedy, or compounds from natural products, that could treat cardiovascular diseases. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41AT003984-01
Application #
7222028
Study Section
Special Emphasis Panel (ZRG1-CVS-K (10))
Program Officer
Pontzer, Carol H
Project Start
2006-09-30
Project End
2008-08-31
Budget Start
2006-09-30
Budget End
2008-08-31
Support Year
1
Fiscal Year
2006
Total Cost
$91,490
Indirect Cost
Name
Invivo Sciences, LLC.
Department
Type
DUNS #
610347713
City
Mcfarland
State
WI
Country
United States
Zip Code
53719
Conway, Michael K; Gerger, Michael J; Balay, Erin E et al. (2015) Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System. J Vis Exp :e52755
Rufanova, Victoriya A; Alexanian, Anna; Wakatsuki, Tetsuro et al. (2009) Pyk2 mediates endothelin-1 signaling via p130Cas/BCAR3 cascade and regulates human glomerular mesangial cell adhesion and spreading. J Cell Physiol 219:45-56
Marquez, Juan Pablo; Legant, Wesley; Lam, Vy et al. (2009) High-throughput measurements of hydrogel tissue construct mechanics. Tissue Eng Part C Methods 15:181-90
Karpushev, Alexey V; Levchenko, Vladislav; Pavlov, Tengis S et al. (2008) Regulation of ENaC expression at the cell surface by Rab11. Biochem Biophys Res Commun 377:521-5